Dividends & Buybacks ·
Scienture Holdings executes 1-for-25 reverse stock split effective October 5 to regain Nasdaq compliance
SCNXScienture Holdings, Inc.
Scienture Holdings executed a one-for-twenty-five reverse stock split of its common shares, effective at 12:01 a.m. Eastern Time on October 5, 2026. The action was taken to restore compliance with Nasdaq’s minimum bid price requirement and to make additional shares available for future issuance. Following the split, the company expects approximately 1,642,565 shares outstanding from a pre-split base of roughly 41 million. Fractional share interests were cashed out rather than issued as partial ownership. Scienture Holdings operates in the pharmaceutical industry, focusing on the development and commercialization of novel specialty products.